InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Mark T Iwicki, CHIEF EXECUTIVE OFFICER, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 12 open-market SEC Form 4 transactions: 0 purchases worth $0 and 12 sales worth $485K, reported from Oct 26, 21 to Oct 23, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 25 | KALAKALA BIO, Inc. | SELL | 154.9K | $0.81 | $125K |
| Jun 24, 25 | KALAKALA BIO, Inc. | SELL | 13.2K | $4.01 | $53K |
| Jun 3, 25 | KALAKALA BIO, Inc. | SELL | 10.9K | $3.74 | $41K |
| Jan 6, 25 | KALAKALA BIO, Inc. | SELL | 5.8K | $7.63 | $44K |
| Jun 26, 24 | KALAKALA BIO, Inc. | SELL | 15.2K | $4.75 | $72K |
| May 31, 24 | KALAKALA BIO, Inc. | SELL | 7.4K | $6.09 | $45K |
| Jan 4, 24 | KALAKALA BIO, Inc. | SELL | 4.5K | $6.73 | $31K |
| Jan 4, 23 | KALAKala Pharmaceuticals, Inc. | SELL | 198 | $28.54 | $6K |
| Oct 26, 22 | KALAKala Pharmaceuticals, Inc. | SELL | 561 | $6.52 | $4K |
| Jun 27, 22 | KALAKala Pharmaceuticals, Inc. | SELL | 8.0K | $0.37 | $3K |
| Jan 4, 22 | KALAKala Pharmaceuticals, Inc. | SELL | 9.5K | $1.30 | $12K |
| Oct 26, 21 | KALAKala Pharmaceuticals, Inc. | SELL | 27.6K | $1.80 | $50K |